Litcius/Paper detail

Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab

Bo Wei, John Kang, Miho Kibukawa, Gladys Arreaza, Maureen G. Maguire, Lei Chen, Ping Qiu, Lixin Lang, Deepti Aurora-Garg, Răzvan Cristescu, Diane Levitan

2022Journal of Molecular Diagnostics54 citationsDOIOpen Access PDF

Topics & Concepts

PembrolizumabConcordanceMedicineOncologyInternal medicineClinical trialCompanion diagnosticImmunotherapyCancerCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsPancreatic and Hepatic Oncology Research
Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab | Litcius